These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6160951)

  • 1. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
    Umapathysivam K; Jones WR
    Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.
    Christensen JT; Boldsen J; Westergaard JG
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):784-9. PubMed ID: 9348259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
    Ammälä M; Nyman T; Strengell L; Rutanen EM
    Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper levels in women using intrauterine devices or oral contraceptives.
    Hefnawi F; Kandil O; Askalani H; Zaki K; Nasr F; Mousa M
    Fertil Steril; 1974 Jul; 25(7):556-61. PubMed ID: 4841618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
    Wang IY; Russell P; Fraser IS
    Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New progress in research on contraceptive technology.
    Han S
    China Popul Newsl; 1986 Feb; 3(1):3-6. PubMed ID: 12268508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
    Johnson IR
    Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
    Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
    Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial response to the use of a sequential oral contraceptive.
    Coppens M; Thiery M
    J Obstet Gynaecol (Lahore); 1988; 8(3):281-4. PubMed ID: 12342312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.